Targeting the stromal androgen receptor in primary prostate tumors at earlier stages.
about
The Androgen Receptor Bridges Stem Cell-Associated Signaling Nodes in Prostate Stem CellsMechanisms of resistance in castration-resistant prostate cancer (CRPC)Involvement of the Androgen and Glucocorticoid Receptors in Bladder CancerAndrogen receptor and prostate cancer stem cells: biological mechanisms and clinical implicationsGenetically engineered mouse models of prostate cancerIntegrated expression profiling and ChIP-seq analyses of the growth inhibition response program of the androgen receptor.NRIP/DCAF6 stabilizes the androgen receptor protein by displacing DDB2 from the CUL4A-DDB1 E3 ligase complex in prostate cancer.Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cellsEpithelial-mesenchymal transition in prostate cancer: an overview.Androgen-induced cell migration: role of androgen receptor/filamin A associationPost-transcriptional regulation of androgen receptor mRNA by an ErbB3 binding protein 1 in prostate cancer.Increased CK5/CK8-positive intermediate cells with stromal smooth muscle cell atrophy in the mice lacking prostate epithelial androgen receptorMolecular genetics of prostate cancer: new prospects for old challengesThe impact of point mutations in the human androgen receptor: classification of mutations on the basis of transcriptional activityStromal androgen receptor in prostate development and cancer.Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription.Role of autonomous androgen receptor signaling in prostate cancer initiation is dichotomous and depends on the oncogenic signal.OTUB1 de-ubiquitinating enzyme promotes prostate cancer cell invasion in vitro and tumorigenesis in vivo.Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth.Altered prostate epithelial development in mice lacking the androgen receptor in stromal fibroblasts.Suppressed prostate epithelial development with impaired branching morphogenesis in mice lacking stromal fibromuscular androgen receptorStromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.Loss of stromal androgen receptor leads to suppressed prostate tumourigenesis via modulation of pro-inflammatory cytokines/chemokinesAndrogen hormone action in prostatic carcinogenesis: stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis.Infiltrating bone marrow mesenchymal stem cells (BM-MSCs) increase prostate cancer cell invasion via altering the CCL5/HIF2α/androgen receptor signals.New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells.Androgen receptor is a tumor suppressor and proliferator in prostate cancer.Suppression of androgen receptor enhances the self-renewal of mesenchymal stem cells through elevated expression of EGFR.The stroma-a key regulator in prostate function and malignancyReduced prostate branching morphogenesis in stromal fibroblast, but not in epithelial, estrogen receptor α knockout miceThe diverse and contrasting effects of using human prostate cancer cell lines to study androgen receptor roles in prostate cancer.Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death.Androgen receptors expressed by prostatic stromal cells obtained from younger versus older males exhibit opposite roles in prostate cancer progression.Stromal Androgen Receptor in Prostate Cancer Development and ProgressionQuality of Life and Sexual Health in the Aging of PCa Survivors.Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails.Androgen regulation of prostate cancer: where are we now?The role of the androgen receptor in the development and progression of bladder cancer.Modeling prostate cancer in mice: something old, something new, something premalignant, something metastatic.Current mouse and cell models in prostate cancer research.
P2860
Q26765892-8D4B7D42-5A5F-4E94-BAFE-3253CA63F197Q26774221-CFFBB11F-507E-47FF-B37B-F78C40EB0CB2Q26782760-22E6DB33-4A32-41A3-8D2B-55E99DA25500Q26797063-3734F531-4BC7-4DE5-9E95-E26356727251Q27026768-C9EDF969-8E72-4FA8-BE62-EFED8B9D6BFAQ33492327-D333F01B-EC0D-4E40-AF04-94E45B354C92Q33591581-C70AA918-94DE-40BD-81A1-EAADCAE749B0Q33694557-C462E320-DF9F-4726-B66A-CC5A10484C8DQ33798864-E735ABA8-FB48-47D5-93FC-A43140FF0C85Q33831959-1E35BBE3-DF70-443A-9CC7-ACC3C836E59EQ33922404-5FE0F27F-B0C9-4728-9D42-42C0A9BCE7B7Q33960272-BA8560AC-8B82-4C60-B53D-81255B5AE43EQ34127462-BBCD661B-C2C5-451D-94F5-6D1AAF98532AQ34189517-D5A12F06-3D80-4C20-BA07-39D0A5B713B6Q34302834-E9702FA9-4F5C-4095-B091-4DA695A33622Q34546701-BCD37AE0-D5C6-44F2-9EF2-1EF049887FE2Q34978001-AF02C019-7587-4A9E-AC7A-36FAEA750C53Q35061299-04517778-40A7-4BC9-8B68-F5D0849E0494Q35168294-AD37188A-EFFC-4DBA-83A7-D9C43F121C7CQ35468922-0E9D5564-D9C0-44B2-B97E-B92487BF51DCQ35640720-990BF422-BBF0-4425-9F7A-06EE8680DD52Q36140754-0EACB9A4-D79E-48E0-9CCA-6131787DE562Q36386464-D0967785-0211-4298-99BC-6C022AC3692EQ36401971-92614A10-1FE6-4A33-8CC9-5551B63E43D5Q36413827-6E8C0EFE-14AD-4ED8-9B4A-50C35338A802Q36582853-3FE0DF35-4B60-4D8F-B200-FE39C342F935Q36858442-00A0EADA-23CC-4541-B53F-434A15B14B0FQ36905079-55258F14-6E38-4F0C-8B69-015D9AF4CA84Q37017028-23B4CF64-514C-4305-8AD2-67EF335A7FEAQ37044256-E0FDDFE5-B18F-44A5-B7EB-A94E831E76B1Q37074725-F1C97AEE-88D5-49D2-B38C-913FB9E454BEQ37322621-5A4A11C2-A66C-48AF-9562-C97C0B02DAD1Q37436975-BCF00EF6-7C90-43C1-A305-28DF82971C80Q37629551-253D2939-CEBB-4D09-8129-525256EA5AE9Q37686901-9738643E-03DA-4E46-A4D1-574C7E51AC36Q37741773-7270CFA8-84E9-4D54-B8E9-F791AFA2ACF4Q37836264-51EF9276-BB26-42B0-9068-F9C3CE2CE969Q38010699-8354DB3B-0A9E-4F31-8970-0955964A13BEQ38056848-3A066889-0E51-4D84-9467-3FEC6F38E799Q38098499-15041738-162D-47F8-A0BD-AB674B94BC8B
P2860
Targeting the stromal androgen receptor in primary prostate tumors at earlier stages.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Targeting the stromal androgen receptor in primary prostate tumors at earlier stages.
@en
type
label
Targeting the stromal androgen receptor in primary prostate tumors at earlier stages.
@en
prefLabel
Targeting the stromal androgen receptor in primary prostate tumors at earlier stages.
@en
P2093
P2860
P356
P1476
Targeting the stromal androgen receptor in primary prostate tumors at earlier stages.
@en
P2093
Chawnshang Chang
Henry Lardy
Kuang-Hsiang Chuang
Kuo-Pao Lai
Saleh Altuwaijri
Shengqiang Yu
Shu-Pin Huang
Shuyuan Yeh
Yuanjie Niu
P2860
P304
12188-12193
P356
10.1073/PNAS.0804701105
P407
P577
2008-08-22T00:00:00Z